相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices
Luvneet Verma et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2018)
Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice
Miriam Almirall et al.
CLINICAL RHEUMATOLOGY (2017)
Long-term drug survival and predictor analysis of the whole psoriatic patient population on biological therapy in Hungary
Lilla Pogacsas et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2017)
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study
Maddalena Napolitano et al.
CLINICAL RHEUMATOLOGY (2017)
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
Leslie R. Harrold et al.
CLINICAL RHEUMATOLOGY (2017)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study
Naba Haque et al.
JOURNAL OF RHEUMATOLOGY (2016)
Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
Arthur Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy
Florenzo Iannone et al.
AUTOIMMUNITY REVIEWS (2016)
Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings
Florenzo Iannone et al.
JOURNAL OF RHEUMATOLOGY (2016)
Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis
Philip J. Mease
CURRENT OPINION IN RHEUMATOLOGY (2015)
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial
Arthur Kavanaugh et al.
ARTHRITIS CARE & RESEARCH (2015)
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher Ritchlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
Arthur Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study
Karen Minde Fagerli et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Obesity and risk of incident psoriatic arthritis in US women
Wenqing Li et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Ustekinumab for psoriatic arthritis
Raquel S. Cuchacovich et al.
LANCET (2009)
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
Alice Gottlieb et al.
LANCET (2009)
The LUNDEX, a new index of drug efficacy in clinical practice - Results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden
LE Kristensen et al.
ARTHRITIS AND RHEUMATISM (2006)
分享论文
